Related Experiment Video

Updated: May 21, 2026

Screening and Identification of Small Peptides Targeting Fibroblast Growth Factor Receptor2 using a Phage Display Peptide Library
07:32

Screening and Identification of Small Peptides Targeting Fibroblast Growth Factor Receptor2 using a Phage Display Peptide Library

Published on: September 30, 2019

Fibroblast growth factor receptor 2: expression, roles, and potential as a novel molecular target for colorectal

Yoko Matsuda1, Junji Ueda, Toshiyuki Ishiwata

  • 1Departments of Pathology and Integrative Oncological Pathology, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo 113-8602, Japan.

Pathology Research International
|June 16, 2012
PubMed

Insights

Fibroblast growth factor receptor 2 (FGFR2) and its isoforms play key roles in colorectal cancer (CRC) progression. Understanding FGFR2 signaling is crucial for developing effective targeted therapies for CRC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • The fibroblast growth factor receptor (FGFR) family has four members (FGFR1-4).
  • FGFRs and their ligands (FGFs) are present in colorectal cancer (CRC).
  • FGFR2 is implicated in cancer progression and is a potential therapeutic target.

Purpose of the Study:

  • To summarize the roles of FGFR2 and its isoforms in CRC.
  • To clarify the therapeutic potential of FGFR2 targeting in CRC.

Main Methods:

  • Review of existing literature on FGFR2 and its isoforms in CRC.
  • Analysis of the roles of FGFR2 isoforms (FGFR2 IIIb and FGFR2 IIIc) in CRC progression.
  • Investigation of FGFR2 signaling pathways (autocrine and paracrine).

Main Results:

  • FGFR2 expression regulates migration, invasion, and growth in CRC.
  • FGFR2 IIIb isoform is linked to well-differentiated CRC and promotes angiogenesis and adhesion.
  • FGFR2 IIIc is detected in CRC, but its functions require further elucidation.
  • FGFR2-FGF interactions may drive CRC via autocrine/paracrine signaling.

Conclusions:

  • FGFR2 and its isoforms are significant in CRC development and progression.
  • Targeting FGFR2 presents a promising therapeutic strategy for CRC.
  • Further research is needed to determine optimal strategies for inhibiting specific FGFR2 isoforms in CRC treatment.

More Related Videos

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors09:04

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors

Published on: March 15, 2016

A Mouse Model to Investigate the Role of Cancer-Associated Fibroblasts in Tumor Growth06:35

A Mouse Model to Investigate the Role of Cancer-Associated Fibroblasts in Tumor Growth

Published on: December 22, 2020

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...